From neural stem cells to glioblastoma: A natural history of GBM recapitulated in vitro

J Cell Physiol. 2021 Nov;236(11):7390-7404. doi: 10.1002/jcp.30409. Epub 2021 May 7.

Abstract

Due to its aggressive and invasive nature glioblastoma (GBM), the most common and aggressive primary brain tumour in adults, remains almost invariably lethal. Significant advances in the last several years have elucidated much of the molecular and genetic complexities of GBM. However, GBM exhibits a vast genetic variation and a wide diversity of phenotypes that have complicated the development of effective therapeutic strategies. This complex pathogenesis makes necessary the development of experimental models that could be used to further understand the disease, and also to provide a more realistic testing ground for potential therapies. In this report, we describe the process of transformation of primary mouse embryo astrocytes into immortalized cultures with neural stem cell characteristics, that are able to generate GBM when injected into the brain of C57BL/6 mice, or heterotopic tumours when injected IV. Overall, our results show that oncogenic transformation is the fate of NSC if cultured for long periods in vitro. In addition, as no additional hit is necessary to induce the oncogenic transformation, our model may be used to investigate the pathogenesis of gliomagenesis and to test the effectiveness of different drugs throughout the natural history of GBM.

Keywords: glioblastoma; metastasis; neural stem cells; replicative senescence.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Brain Neoplasms / metabolism*
  • Brain Neoplasms / pathology
  • Cell Line, Transformed
  • Cell Proliferation
  • Cell Transformation, Neoplastic / metabolism*
  • Cell Transformation, Neoplastic / pathology
  • Glioblastoma / metabolism*
  • Glioblastoma / pathology
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Neoplasm Metastasis
  • Neural Stem Cells / metabolism*
  • Neural Stem Cells / pathology
  • Phenotype
  • Tumor Burden